Navigation Links
US Blood Typing, Grouping and Infectious Disease Screening Market 2013: Sales Forecasts, Supplier Shares, Competitive Strategies
Date:10/28/2013

London (PRWEB) October 28, 2013

Summary

This comprehensive report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the US blood banking market during the next five years, and assist industry executives in developing effective business, new product development and marketing strategies.

The report explores future marketing and technological trends in the US; provides test volume and sales forecasts by market segment/test location; compares features of major automated and semi-automated analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next five years.

I. Introduction
II. Worldwide Technology and Market Overview
A. Major Blood Typing, Grouping and Infectious
Disease Screening Tests
1. Blood Typing and Grouping Tests
2. Infectious Disease Screening Tests
a. AIDS
b. Hepatitis
c. Cytomegalovirus
d. Syphilis
e. West Nile Virus
f. Parvovirus B19
g. Creutzfeldt-Jakob’s Disease
h. Malaria
i. Chagas Disease
j. Babesiosis
3. Pathogen Reduction
4. Leukocyte Reduction
B. Instrumentation Review: Operating Characteristics,
Features and Selling Prices of Leading Automated
and Semiautomated Analyzers
C. Major in Vitro Diagnostic Technologies
And Their Potential Applications
1. Molecular Diagnostics
2. Monoclonal and Polyclonal Antibodies
3. Immunoassays
4. Microtitration Plates
5. IT and Automation
6. Lasers
7. Robotics
8. Synthetic Red Cell Substitutes
9. Genetically Engineered Blood Components
10. Blood Preservation
11. Autologous Blood Transfusion/Freezing
III. US
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Suppliers’
Sales and Market Shares for Blood Typing, Grouping
and Infectious Disease Screening Tests
IV. Major Product Development Opportunities
A. Blood Typing and Grouping
B. Infectious Disease Screening
C. Auxiliary
V. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
VI. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
VII. Competitive Assessments
-Abbott
-Beckman Coulter/Danaher
-Becton Dickinson
-Biokit
-BioMerieux
-Bio-Rad
-Diagast
-DiaSorin
-Fujirebio/Innogenetics
-Hologic/Gen-Probe
-Grifols
-Immucor
-Novartis Diagnostics
-Ortho-Clinical Diagnostics
-Orchid CellMark
-Proteome Sciences
-Quest Diagnostics
-Quidel
-Roche
-Siemens
-Tecan
XII. Appendix: Assumed Currency Exchange Rates

List of Tables

Major Companies Developing or Marketing
Blood Typing and Grouping Tests
Major Companies Developing or Marketing
HLA Typing Tests
Major Companies Developing or Marketing
AIDS Tests
Major Companies Developing or Marketing
Hepatitis Tests
Major Companies Developing or Marketing
CMV Tests
Major Companies Developing or Marketing
Syphilis Tests
Major Companies Developing or Marketing
Blood Bank Analyzers
Executive Summary Table: U.S.A., Total Blood Bank
Test Volume and Reagent Sales Forecast
by Test Category
U.S.A., Estimated Number of Inpatient and
Ambulatory Surgeries
U.S.A., Facilities Performing Blood
Bank Tests by Market Segment
U.S.A., Hospital Laboratories Performing
Blood Bank Tests by Bed Size
U.S.A., Commercial/Private Laboratories
Performing Blood Bank Tests
by Annual Test Volume Forecast
U.S.A., Facilities Collecting Whole Blood
And Plasma by Market Forecast Segment
U.S.A., Whole Blood and Plasma Collections
By Market Forecast Segment
U.S.A., All Market Segments Blood Typing
and Grouping Test Volume by Market Forecast
Segment
U.S.A., All Market Segments Blood Typing
And Grouping Test Volume Forecast
U.S.A., Hospital Laboratories Blood
Typing and Grouping Test Volume Forecast
U.S.A., Community and Regional Blood Centers
Blood Typing and Grouping Test Volume Forecast
U.S.A., Commercial/Private Laboratories
Blood Typing and Grouping Test Volume Forecast
U.S.A., Plasma Fractionation Centers Blood
Typing and Grouping Test Volume Forecast
U.S.A., Military Blood Banks Blood Typing
and Grouping Test Volume Forecast
U.S.A., All Market Segments Infectious
Disease Screening Test Volume Forecast
By Market Segment
U.S.A., All Market Segments Infectious
Disease Screening Test Volume Forecast
U.S.A., Community and Regional Centers
Infectious Disease Screening Test Volume Forecast
U.S.A., Plasma Fractionation Centers
Infectious Disease Screening Test Volume Forecast
U.S.A., Hospital Blood Banks
Infectious Disease Screening Test Volume Forecast
U.S.A., Military Blood Banks Infectious
Disease Screening Test Volume Forecast
U.S.A., All Market Segments Blood Typing
And Grouping Reagent Market Forecast
by Market Segment
U.S.A., All Market Segments Blood Typing
And Grouping Reagent Market Forecast
by Market Segment
U.S.A., Hospital Blood Banks Blood Typing
And Grouping Reagent Market Forecast
by Major Test
U.S.A., Community and Regional Blood Centers
Blood Typing and Grouping Reagent Market Forecast
By Major Test
U.S.A., Commercial/Private Laboratories
Blood Typing and Grouping Reagent Market Forecast
By Major Test
U.S.A., Plasma Fractionation Centers
Blood Typing and Grouping Reagent Market Forecast
By Major Test
U.S.A., Military Blood Banks Blood Typing
And Grouping Reagent Market Forecast by Major Test
U.S.A., All Market Segments Infectious
Disease Screening Reagent Market by Market Forecast
Segment
U.S.A., All Market Segments Infectious
Disease Screening Reagent Market by Market Forecast
Segment
U.S.A., Community and Regional Centers
Infectious Disease Screening Reagent Market Forecast
By Test
U.S.A., Plasma Fractionation Centers
Infectious Disease Screening Reagent Market Forecast
By Test
U.S.A., Hospital Blood Banks
Infectious Disease Screening Reagent Market Forecast
By Test
U.S.A., Military Blood Banks Infectious
Disease Screening Reagent Market Forecast
By Test
U.S.A., Major Suppliers of Blood Typing
And Grouping Reagents Estimated Sales
And Market Shares
U.S.A., HIV/HTLV Blood Screening Market,
Reagent Sales by Major Supplier
U.S.A., Hepatitis Blood Screening Market,
Reagents Sales by Major Supplier
U.S.A., Hepatitis C Blood Screening Market,
Reagent Sales By Major Supplier
U.S.A., HIV/Hepatitis C NAT Market, Reagent
Sales By Major Supplier
U.S.A., West Nile Virus NAT Market,
Reagent Sales by Major Supplier
U.S.A., CMV Blood Screening Market,
Reagent Sales by Major Supplier
U.S.A., Syphilis Blood Screening Market,
Reagent Sales by Major Supplier

Read the full report:

US Blood Typing, Grouping and Infectious Disease Screening Market 2013: Sales Forecasts, Supplier Shares, Competitive Strategies

http://www.reportbuyer.com/pharma_healthcare/diagnostics/us_blood_typing_grouping_infectious_disease_screening_market_2013_sales_forecasts_supplier_shares_competitive_strategies.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: query@reportbuyer.com
Tel: +44 208 816 85 48
Website: http://www.reportbuyer.com

Read the full story at http://www.prweb.com/releases/2013/10/prweb11274758.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Infection Might Raise Blood Clot Risk for Older Adults: Study
2. Normalizing tumor blood vessels improves delivery of only the smallest nanomedicines
3. Common Blood Pressure Drug Safe for Heart Failure: Study
4. Certain Birth Control Pills May Carry Higher Blood Clot Risk: FDA
5. High Blood Pressure May Be Especially Lethal for Blacks
6. Changes in gene expression may help explain high blood pressure in pregnancy
7. Researchers Develop Blood Test for Depression
8. Naturopathic care can improve blood sugar, mood in diabetes
9. Diabetes Groups Issue New Guidelines on Blood Sugar
10. Exercise May Help Patients With High Blood Pressure Live Longer
11. Additional blood pressure screening may reduce incidence of CVD events and death by up to 3 percent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2016)... ... , ... Are You Concerned About Mold In Your Home or Workplace? ... Companies in VA, MD and DC, recently completed its application for the new District ... in the district of Columbia is a good thing stated John Taylor, Owner of ...
(Date:12/2/2016)... ... December 02, 2016 , ... Lori G. Cohen and Sara ... speak at the American Conference Institute’s 21st Drug & Medical Device Litigation Conference ... Sponsor of the conference. , Cohen, who chairs the firm’s Pharmaceutical, Medical Device & ...
(Date:12/2/2016)... Los Angeles, CA (PRWEB) , ... December 02, 2016 , ... For over twenty-four years, ... a lien basis to help personal injury victims find high quality medical care. When ... the Los Angeles area. Fast forward to present day and the now ten-page directory ...
(Date:12/2/2016)... ... December 02, 2016 , ... FlexiSpot, ... of its 60-day free trial program for all of the company’s desktop riser ... a truly hassle free experience. , FlexiSpot’s unique desktop risers use an advanced ...
(Date:12/2/2016)... New York, NY (PRWEB) , ... December 02, 2016 , ... ... Through an exclusive interview with Mediaplanet, Dr. Murthy explains how he was inspired to ... “Early on I learned that medicine is about more than making diagnoses and prescribing ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... -- Seno Medical Instruments, Inc., the company pioneering the development ... the process of diagnosing breast cancer, today announced that ... surveillance and clinical follow-up study at the 2016 ... from December 6-10, 2016 at the Henry B. Gonzalez ... . Seno Medical Instruments will present two ...
(Date:12/5/2016)... and TAIPEI, Taiwan , Dec. ... months of treatment ropeginterferon alfa-2b showed non-inferiority to hydroxyurea (HU) ... a significantly better safety and tolerability profile of ropeginterferon alfa-2b ... from PROUD-PV and the ongoing long-term follow-up trial CONTINUATION-PV to ... PharmaEssentia intends to present this data to the FDA ...
(Date:12/4/2016)... 3, 2016 Sickle cell disease (SCD) is ... blood cells that get stuck in veins and block ... failure, and complications leading to death. Each year, approximately ... and most of them lack access to comprehensive care ... long-term therapy for SCD, a pill called hydroxyurea approved ...
Breaking Medicine Technology: